Skip to Content
Merck
CN

[Atenolol in treatment of patients with airway obstruction].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (1996-12-01)
R Chazan
ABSTRACT

It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.

MATERIALS
Product Number
Brand
Product Description

Supelco
Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®